ArticleBiomimetics (Basel, Switzerland)2025
Design and Validation of a Piston-Driven Syringe-Extrusion Bioprinter Using an FDM Frame.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct ink writing (DIW) deposits viscous, shear-responsive inks at low temperature, enabling hydrogels and cell-laden bioinks for biomedical fabrication. Access to DIW remains limited by the cost of dedicated systems and the complexity of custom motion control. Repurposing fused deposition modeling (FDM) printers lowers these barriers by using accurate motion stages, open firmware, and familiar workflows while preserving build volume. In this study, three DIW actuator designs were implemented on an FDM frame. The first used a gear-and-rail transmission that converted stepper rotation to plunger travel. The second used a direct trapezoidal-screw pusher that increased force but reduced build-space clearance. The third relocated actuation to a remote piston-driven module that decoupled force generation from the printhead. The final architecture integrates the remote piston with partitioned control, where the printer executes motion and a programmable logic controller (PLC) manages extrusion. This arrangement reduces carried mass, preserves build space, and enables precise volumetric dosing with fast response. On a standard desktop frame, the system achieved controllable deposition of an agar/alginate ink using off-the-shelf electronics and modest modifications. This approach promotes sustainable and accessible innovation by repurposing existing FDM printers with open-source hardware and modular components. The resulting platform supports biomimetic biofabrication by combining mechanical efficiency, environmental responsibility, and cost-effective design.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.